🔎 Trials Near Me

Nyumbani › Multiple Myeloma › Iowa › Cedar Rapids

Majaribio ya kliniki ya Multiple Myeloma katika Cedar Rapids, IA

Masomo 15 ya Multiple Myeloma yanatafuta washiriki katika vituo vya Cedar Rapids na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.

Maandishi rasmi ya utafiti (Kiingereza)

Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

InaajiriHatua 3
  • University of Iowa Hospitals and Clinics, Iowa City · Mi 25 mbali
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT07518186

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

InaajiriHatua 3
  • University of Iowa Hospital and Clinics, Iowa City · Mi 25 mbali
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT07258511

Collection of Tissue Samples for Cancer Research

InaajiriUtafiti wa uchunguzi
  • University of Iowa, Iowa City · Mi 25 mbali
2 Months · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT00900198

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

InaajiriHatua 2
  • University of Iowa, Iowa City · Mi 25 mbali
Umri 18 na zaidi · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT06297226

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

InaajiriHatua 3
  • Mercy Hospital, Cedar Rapids
  • Oncology Associates at Mercy Medical Center, Cedar Rapids
Umri 18 na zaidi · Jinsia zote · Imesasishwa 19 Ago 2026 · NCT04566328

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

InaajiriHatua 1/2
  • Research Site, Iowa City · Mi 25 mbali
Umri 18 na zaidi · Jinsia zote · Imesasishwa 17 Ago 2026 · NCT05850234

Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

InaajiriHatua 3
  • Research Site, Iowa City · Mi 25 mbali
Umri 18 na zaidi · Jinsia zote · Imesasishwa 14 Ago 2026 · NCT07764978

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

InaajiriHatua 2
  • University of Iowa, Iowa City · Mi 25 mbali
Umri 18 na zaidi · Jinsia zote · Imesasishwa 6 Ago 2026 · NCT07284758

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

InaajiriHatua 3
  • Physicians' Clinic of Iowa PC, Cedar Rapids
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · Mi 25 mbali
Umri wote · Jinsia zote · Imesasishwa 10 Jun 2026 · NCT05561387

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

InaajiriHatua 2
  • University of Iowa, Iowa City · Mi 25 mbali
Umri 19 na zaidi · Jinsia zote · Imesasishwa 4 Jun 2026 · NCT06974786

Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma

InaajiriHatua 1
  • University of Iowa Health Care, Iowa City · Mi 25 mbali
Umri 18 na zaidi · Jinsia zote · Imesasishwa 4 Jun 2026 · NCT07581704

Sleep Apnea in Patients With MGUS and MM

InaajiriUtafiti wa uchunguzi
  • University of Iowa, Iowa City · Mi 25 mbali
Umri 18 hadi 99 · Jinsia zote · Imesasishwa 10 Nov 2025 · NCT04114084

Activity Levels in Bone Marrow Transplant Patients

InaajiriUtafiti wa uchunguzi
  • University of Iowa, Iowa City · Mi 25 mbali
Umri 18 hadi 99 · Jinsia zote · Imesasishwa 10 Nov 2025 · NCT04115241

Limited-duration Teclistamab

InaajiriHatua 2
  • University of Iowa Hospitals and Clinics, Iowa City · Mi 25 mbali
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Okt 2025 · NCT05932680

Majaribio ya Multiple Myeloma katika miji mingine

Masomo mengine katika Cedar Rapids

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.